PATENT CLAIM ANALYSIS

Application Number: 16177159
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "183000"]

Abstract:
Provided herein are stable enalapril oral liquid formulations. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.

Claim (Index 11):
The stable oral liquid formulation of  claim 1 , wherein the pH of the stable oral liquid formulation is about 3.3.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 1.27586
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15081603', '15613622', '16003994', '15802341', '15483691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7968008667532969
- 35 USC 102 Novelty (BERT): 0.5935088674821375
- Combined Prediction Score: 0.776471666826181
- Mean Citation Score: 455.904018
- Max Citation Score: 484.54633
- Similarity Product: 464.1965414679223

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test